PUMA BIOTECHNOLOGY, INC.
Cash Flow Statement
| Line Item | Jun 2014 | Mar 2014 | Dec 2013 | Sep 2013 | Jun 2013 | Mar 2013 | Dec 2012 | Sep 2012 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-38.8M | $-19.8M | $-15.9M | $-14.3M | $-12.7M | $-11.8M | $-21.9M | $-25.9M |
| Depreciation & Amortization | $146.0K | $133.0K | $125.0K | $109.0K | $99.0K | $90.0K | $77.7K | $68.8K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $7.2M | $5.2M | $3.1M | $1.8M | $1.4M | $1.2M | $18.8M | $358.0K |
| Net Cash from Operating Activities | $17.4M | $-17.0M | $-13.6M | $-12.0M | $-11.0M | $-18.5M | $-24.8M | $-7.6M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $3.3M | $2.2M | $-19.8M | $-27.3M | $-389.0K | $-11.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | — | — | — | — | — | — |
| Net Change in Cash | $-108.0M | $120.3M | $-8.2M | $-9.6M | $-30.7M | $-45.8M | $104.1M | $-7.7M |
| Free Cash Flow | — | — | — | — | — | — | — | — |